Park JY et al. |
Monitoring the status of T-cell activation in a microfluidic system. |
2011 |
Analyst |
pmid:21623432
|
Menotta M et al. |
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy. |
2015 |
Anal. Chim. Acta |
pmid:26073814
|
Gómez-RÃos GA et al. |
Rapid determination of immunosuppressive drug concentrations in whole blood by coated blade spray-tandem mass spectrometry (CBS-MS/MS). |
2018 |
Anal. Chim. Acta |
pmid:29254576
|
Wada A et al. |
Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. |
2014 |
Anal. Chem. |
pmid:24380432
|
Hopper JT and Oldham NJ |
Alkali metal cation-induced destabilization of gas-phase protein-ligand complexes: consequences and prevention. |
2011 |
Anal. Chem. |
pmid:21863818
|
Sage L |
Fishing for MAGIC targets. |
2005 |
Anal. Chem. |
pmid:16285140
|
Murakami Y et al. |
On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506). |
2004 |
Anal. Biochem. |
pmid:15464959
|
Sellar KJ et al. |
Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood. |
2006 |
Anal. Biochem. |
pmid:16979577
|
Cañadas O et al. |
Equilibrium studies of a fluorescent tacrolimus binding to surfactant protein A. |
2005 |
Anal. Biochem. |
pmid:15802130
|
Carreras CW et al. |
An FKBP12 binding assay based upon biotinylated FKBP12. |
2001 |
Anal. Biochem. |
pmid:11673895
|
Ahn SC et al. |
A tactic for screening inhibitors of interleukin-2 production. |
2002 |
Anal. Biochem. |
pmid:12018952
|
Park JW et al. |
Liquid chromatography-mass spectrometry characterization of FK506 biosynthetic intermediates in Streptomyces clavuligerus KCTC 10561BP. |
2009 |
Anal. Biochem. |
pmid:19539594
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
Blanchet B et al. |
Determination of serine/threonine protein phosphatase type 2B PP2B in lymphocytes by HPLC. |
2003 |
Anal. Biochem. |
pmid:12479828
|
Ohtsu Y et al. |
Selective ligand purification using high-performance affinity beads. |
2005 |
Anal. Biochem. |
pmid:15745744
|
Rupprecht KR et al. |
Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs. |
2010 |
Anal. Biochem. |
pmid:20696124
|
Nozaki K et al. |
Elimination technique for alkali metal ion adducts from an electrospray ionization process using an on-line ion suppressor. |
2010 |
Anal Sci |
pmid:20543506
|
den Burger JC et al. |
Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry. |
2012 |
Anal Bioanal Chem |
pmid:22899246
|
Neu V et al. |
On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate. |
2012 |
Anal Bioanal Chem |
pmid:22797715
|
Takahashi T et al. |
Isolating the whole complex of target proteins of FK506 using affinity resins from novel solid phases. |
2006 |
Anal Bioanal Chem |
pmid:16601955
|
Tomás ML |
[Immunosuppressive agents: side effects]. |
1997 |
An R Acad Nac Med (Madr) |
pmid:9616947
|
Navas López VM et al. |
[Safety and efficacy of oral tacrolimus in the treatment of paediatric inflammatory bowel disease]. |
2009 |
An Pediatr (Barc) |
pmid:19427822
|
Zahdi MR et al. |
Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. |
2013 Sep-Oct |
An Bras Dermatol |
pmid:24173187
|
Delgado L et al. |
Zoon's plasma cell balanitis: a report of two cases treated with pimecrolimus. |
2011 Jul-Aug |
An Bras Dermatol |
pmid:22068766
|
Viana Fde O et al. |
Acral lichen sclerosus et atrophicus--case report. |
2011 Jul-Aug |
An Bras Dermatol |
pmid:22068779
|
Cakici O et al. |
Periorbital discoid lupus: a rare localization in a patient with systemic lupus erythematosus. |
|
An Bras Dermatol |
pmid:28300917
|
Lima RS et al. |
Granuloma faciale: a good therapeutic response with the use of topical tacrolimus. |
|
An Bras Dermatol |
pmid:26560220
|
Sisti A et al. |
Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. |
2016 |
An Bras Dermatol |
pmid:27192518
|
Tamler C et al. |
Tacrolimus 0,1% ointment in the treatment of vitiligo: a series of cases. |
2011 Jan-Feb |
An Bras Dermatol |
pmid:21437550
|
Holmgren G et al. |
Successful pregnancies and fatherhood in familial amyloidotic polyneuropathy (FAP Val30Met) patients with liver transplantation. |
2004 |
Amyloid |
pmid:15478469
|
Fix OK et al. |
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis. |
2016 |
Amyloid |
pmid:26972447
|
Kyles AE et al. |
Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats. |
2000 |
Am. J. Vet. Res. |
pmid:10951980
|
Kyles AE et al. |
Pharmacokinetics of tacrolimus after multidose oral administration and efficacy in the prevention of allograft rejection in cats with renal transplants. |
2003 |
Am. J. Vet. Res. |
pmid:12856780
|
Arango C et al. |
A 29-year-old renal transplant recipient with acute respiratory failure. |
2012 |
Am. J. Trop. Med. Hyg. |
pmid:22665592
|
Spada M et al. |
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. |
2006 |
Am. J. Transplant. |
pmid:16771811
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Cavadas PC et al. |
Bilateral trans-humeral arm transplantation: result at 2 years. |
2011 |
Am. J. Transplant. |
pmid:21521475
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Trofe-Clark J et al. |
Immunosuppression, generic drugs and the FDA. |
2012 |
Am. J. Transplant. |
pmid:22176626
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
Krenzien F et al. |
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:27754593
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Zafrani L et al. |
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. |
2009 |
Am. J. Transplant. |
pmid:19538494
|
Touzot M et al. |
Renal transplantation in HIV-infected patients: the Paris experience. |
2010 |
Am. J. Transplant. |
pmid:20840478
|
Krämer BK et al. |
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. |
2010 |
Am. J. Transplant. |
pmid:20840480
|
TruneÄka P et al. |
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20840481
|
Wang Q et al. |
Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion. |
2004 |
Am. J. Transplant. |
pmid:15084166
|
Schubert M et al. |
Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. |
2004 |
Am. J. Transplant. |
pmid:15084173
|
ter Meulen CG et al. |
Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. |
2004 |
Am. J. Transplant. |
pmid:15084178
|
Borrows R et al. |
Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation. |
2004 |
Am. J. Transplant. |
pmid:15476485
|
Hernández-Fisac I et al. |
Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. |
2007 |
Am. J. Transplant. |
pmid:17725683
|
Budde K et al. |
Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20121745
|
Hanto DW et al. |
Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. |
2010 |
Am. J. Transplant. |
pmid:20977633
|
Al-Massarani G et al. |
Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
2008 |
Am. J. Transplant. |
pmid:18925903
|
Frassetto LA and Benet LZ |
Pharmacogenomics and transplantation: where are we? |
2004 |
Am. J. Transplant. |
pmid:15147415
|
MacPhee IA et al. |
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15147425
|
Artz MA et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15147428
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Hesselink DA et al. |
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. |
2005 |
Am. J. Transplant. |
pmid:15816878
|
Byrne GW et al. |
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. |
2005 |
Am. J. Transplant. |
pmid:15816881
|
Lucey MR et al. |
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. |
2005 |
Am. J. Transplant. |
pmid:15816894
|
Pillebout E et al. |
Renal histopathological lesions after orthotopic liver transplantation (OLT). |
2005 |
Am. J. Transplant. |
pmid:15816895
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Van Laecke S et al. |
Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19624560
|
Srinivas TR et al. |
The noninferiority trial: don't don't do it. |
2010 |
Am. J. Transplant. |
pmid:21087412
|
Madariaga ML et al. |
Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. |
2015 |
Am. J. Transplant. |
pmid:25824550
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Sindhi R et al. |
Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection. |
2005 |
Am. J. Transplant. |
pmid:15636616
|
Shergill AK et al. |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:15636619
|
Tydén G et al. |
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. |
2005 |
Am. J. Transplant. |
pmid:15636623
|
Woodle ES et al. |
A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. |
2005 |
Am. J. Transplant. |
pmid:15636625
|
Mian AN et al. |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. |
2005 |
Am. J. Transplant. |
pmid:15636628
|
Gregoor PS and Weimar W |
Tacrolimus and pure red-cell aplasia. |
2005 |
Am. J. Transplant. |
pmid:15636632
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Lemahieu WP et al. |
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. |
2004 |
Am. J. Transplant. |
pmid:15307840
|
Pondrom S |
The AJT report. |
2008 |
Am. J. Transplant. |
pmid:18324976
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Servais A et al. |
Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. |
2011 |
Am. J. Transplant. |
pmid:21672152
|
Mazariegos GV et al. |
Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. |
2005 |
Am. J. Transplant. |
pmid:15643991
|
Bahra M et al. |
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. |
2005 |
Am. J. Transplant. |
pmid:15644002
|
Ryan CM and Swanson DP |
clinical research, innovative practice and IRB review: identifying and respecting boundaries. |
2007 |
Am. J. Transplant. |
pmid:17331113
|
Min SI et al. |
Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. |
2013 |
Am. J. Transplant. |
pmid:23734831
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Margreiter R et al. |
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. |
2008 |
Am. J. Transplant. |
pmid:18510632
|
Miller LW |
Cardiovascular toxicities of immunosuppressive agents. |
2002 |
Am. J. Transplant. |
pmid:12392286
|